|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
https://www.pathologynews.com/wp-content/uploads/2025/03/Aiforia-Logo-4.png Experimental image-based AI models are very good at extracting new information from standard H&E pathology slides. However, the biological interpretation of these novel findings is a challenge. In this webinar, Dr. Anna Laury, Clinical Researcher at the University of Helsinki, will explain how they used scanned H&E slides of high-grade serous carcinoma of the tube/ovary (HGSC) [...] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
https://www.pathologynews.com/wp-content/uploads/2025/03/Aiforia-Logo-4.png Join this webinar to discover how digital pathology with AI evaluation is a more sensitive method for HER2-low assessment. Dr. Anikó Kovács (Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden) will present findings from a retrospective study on the HER2-low status of advanced breast carcinomas in core biopsies. The aim of the study was to: [...] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
